Table 3.
15D | ||||||
---|---|---|---|---|---|---|
Baseline level | 6-month F-U | p value | 12-month F-U | p value | Control population | |
THA | ||||||
n | 802 | 574 | 569 | |||
Mean 15D (SD, 95% CI) | 0.824 | 0.888 | 0.886 | 0.901 | ||
Change of the mean 15D (SD, 95% CI) | 0.064 (0.076, 0.058–0.070) | <0.001 | 0.062 (0.083, 0.055–0.069) | <0.001 | ||
TKA | ||||||
n | 1017 | 750 | 731 | |||
Mean 15D (SD, 95% CI) | 0.837 | 0.869 | 0.870 | 0.896 | ||
Change of the mean 15D (SD, 95% CI) | 0.032 (0.074, 0.026–0.037) | <0.001 | 0.033 (0.076, 0.028–0.039) | <0.001 |
F-U: follow-up; THA: total hip arthroplasty; SD: standard deviation; CI: confidence interval; TKA: total knee arthroplasty.